REFERENCES
- Amole, B. A., Wittner, M., Hewlett, D. & Tanowitz H. B. (1985). Trypanosomabrucei: infection in murinediabetes. Experimental Parasitology, 60, 343–347.
- Bracha, H. S. & Kleinman, J. E. (1986). Postmortem neurochemistry in schizophrenia. Psychiatric Clinics of North America, 9, 133–141.
- Brennessel, D., Wittner, M., Braunstein, V. & Tanowitz, H. B. (1985). Acetylcholinesterase in murine Chagas' disease. American Journal of Tropical Medicine and Hygiene, 34, 460–464.
- Brohn, F. H. & Clarkson, A. B. (1978). Quantitative effects of salcyhydroxamic acid and glycerol on Trypanosoma hrucei glycolysis in vitro and in vivo. Acta Tropica, 35, 22–33.
- Brown, G. L., Ebert, M. H., Goyer, P. F., Jimerson, D. C., Klein, W., Bunney, W. F. & Goodwin, F. K. (1982). Aggression, suicide, and serotonin: relationships to CSF amine metabolites. American Journal of Psychiatry, 139, 741–746.
- Davies, P. & Feisullin, S. (1980). Postmortem stability of bungarotoxin binding sites in mouse and human brain. Brain Research, 216, 449–454.
- Farley, I. J., Price, K. S., McCollough, E., Deck, J. H. N., Hordynski, W. & Hornykiewicz, O. (1978). Norepinephrine in chronic paranoid schizophrenia: Above-normal levels in limbic forebrain. Science, 200, 456–458.
- Fonnum, F. (1969). Radiochemical microassays for thedetermination ofcholine acetyltransferase and acetylcholinesterase activity. Biochemical Journal, 125, 465–472.
- Hornykiewicz, O. (1982). Brain catecholeamines in schizophrenia—a good case for noradrenaline. Nature, 299, 484–486.
- Jennings, F. W., Whitelaw, D. D. & Urquhart, G. M. (1977). The relationship between duration of infection with Trypanosoma brucei in mice and the efficacy of chemotherapy. Parasitology, 75, 143–153.
- Jennings, F. W., Whitelaw, D. D., Holmes, P. H., Chizy, U. & Urquhart, G. M. (1979). Brain as a source of relapsing Trypanosoma brucei infection in mice after chemotherapy. International Journal for Parasitology, 9, 381–384.
- Lambo, T. A. (1966). Neuropsychiatric syndromes associated with human trypanosomiasis in tropical Africa. Acta Psychiatrica Scandinavica, 42, 474–484.
- Osteroff, R. B., Giller, E., Harkness, L. & Mason, J. (1985). The norepinephrine-epinephrine ratio in patients with a history of suicide attempts. American Journal of Psychiatry, 142, 224–227.
- Poltera, A. A., Hochman, A., Rudin, W. & Lambert, P. H. (1980). Trypanosoma hrucei hrucei: a model for cerebral trypanosomiasis in mice—an immunological, histological and electron microscopic study. Clinical and Experimental Immunology, 60, 1253–1256.
- Stibbs, H. H. (1984a). Effects of African trypanosomiasis on brain levels of dopamine, serotonin, 5-hydroxyindoleacetic acid, and homovanillic acid in the rabbit. Journal of Neurochemistry, 43, 1253–1256.
- Stibbs, H. H. (1984b). Neurochemical and activity changes in rats infected with Trypanosoma brucei gambiense. Journal of Parasitology, 70, 428–432.
- Stibbs, H. H. & Curtis, D. A. (1987). Neurochemical changes in experimental African trypanosomiasis in voles and mice. Annals of Tropical Medicine and Parasitology, 81, 673–679.
- Stibbs, H. H. & Seed, J. R. (1973). Chromatographic evidence for the synthesis of possible sleep mediators in Trypanosoma bruceigambiense. Experientia, 29, 1563–1565.
- Stibbs, H. H. & Seed, J. R. (1975a). Short-termmetabolism of 14C-tryptophan in rats infected with Trypanosoma brucei gambiense. Journal of Infectious Diseases, 1312, 459–462.
- Stibbs, H. H. & Seed, J. R. (1975b). Further studies on the metabolism in tryptophan in Trypanosoma brucei gambiense: cofactors, inhibitors, and end-products. Experientia, 31, 274–277.
- Tanowitz, H. B., Davies, P., Factor, S. & Wittner, M. (1981). Trypanosoma cruzi: choline acetyltransferase activity in tissues of susceptible and resistant mice infected with the Brazil strain. Experimental Parasitology, 51, 269–278.
- Tanowitz, H. B., Davies, P. & Wittner, M. (1983). Alterations in acetylcholine receptors in experimental Chagas' disease. Journal of Infectious Diseases, 147, 460–466.
- TraksMan, L., Asberg, M., Bertilsson, L. & Sjostrand, L. (1981). Monoaminemetabolism in cerebral spinal fluid and suicide behavior. Archives of General Psychiatry, 38, 631–636.
- Van Kammen, D. P., Pϵτϵρ, J. & Van Kammen, W. B. (1986). Cerebral spinal fluid studies of monoamine metabolism in schizophrenia. Psychiatric Clinics of North America, 9, 81–87.